Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
2.50
Ask:
2.80
Spread: 0.30 (12.00%)
Market Cap: £4.56m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

US Customer partnership update

21 Jun 2019 07:00

RNS Number : 9660C
Nanoco Group PLC
21 June 2019
 

21 June 2019

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

 

US Customer partnership update

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, today updates the market on its business with its US Customer (the 'US Company').

In January 2019, the Group announced a major contract extension to its initial agreement with the US Customer, covering a range of stress testing and commissioning services of the Runcorn facility in the twelve month period to December 2019.

The US Customer has now informed Nanoco that the project will not continue beyond the current contract, for reasons wholly unconnected to the performance of our materials and our service delivery. Other potential uses for the technology are being explored with a range of customers, including the US Customer. The Group also continues to work on a number of opportunities in a range of sectors including display.

This decision does not affect the current contract which runs until the end of December 2019. The Group still expects to deliver a cash breakeven positon, as previously announced, for the twelve months ending December 2019 and to have a cash balance of approximately £6.0m at that time.

At this time, revenues and associated cash flows under contract for the next financial year ending 31 July 2020 amount to approximately £4.0m, the majority of which are included in the forecast cash position at 31 December 2019.

This announcement contains inside information as defined in EU Regulation No. 596/2014 and is in accordance with the Group's obligations under Article 17 of that Regulation.

 

The person responsible for arranging for the release of this announcement on behalf of the Group is Brian Tenner, Chief Operating Officer and Chief Financial Officer.

 

For further information, please contact:

Nanoco Group PLC

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

 

Brian Tenner, Chief Financial Officer

 

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFMGZVFGNGLZZ
Date   Source Headline
28th Oct 20247:00 amRNSReceipt of General Meeting Requisition Notice
23rd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Oct 20247:00 amRNSAppointment of CEO and Notice of Results
22nd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20247:00 amRNSConclusions of Strategic Review
1st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 202410:51 amRNSHolding(s) in Company
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20241:08 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20241:34 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Aug 20247:00 amRNSCommercial Update
29th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:21 amRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20249:16 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20247:00 amRNSBoard and Management Change
25th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.